Elsevier Inc.

SHERPA: Unknown

People

  1. Hudis
    Hudis
  2. Norton
    Norton
  3. Seidman
    Seidman
  4. D'Andrea-Carlino
    D'Andrea-Carlino
  5. Lake
    Lake
  6. Modi
    Modi
  7. Bach
    Bach
  8. Fornier
    Fornier
  9. Gilewski
    Gilewski
  10. Patil
    Patil

Groups

  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (5)
  2. Breast Medicine Service (5)
  3. Department of Medicine (5)
  4. Solid Tumor Oncology Division (5)
  5. Survivorship Research (5)
  6. Biostatistics Service (3)
  7. Epidemiology and Biostatistics (3)
  8. Behavioral Sciences Service (2)
  9. Body Imaging Service (2)
  10. Gynecologic Medicine Service (2)
Search Within
  1. "Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center "
  2. "Survivorship Research"
  3. "Andrew Seidman"
  4. "Clinical Breast Cancer"
Formats
  1. Journal Article (5)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (5)
  2. Breast Medicine Service (5)
  3. Department of Medicine (5)
  4. Solid Tumor Oncology Division (5)
  5. Survivorship Research (5)
  6. Biostatistics Service (3)

More Groups

People
  1. Andrew Seidman (5)
  2. Clifford Hudis (5)
  3. Larry Norton (5)
  4. Gabriella D'Andrea-Carlino (4)
  5. Diana Lake (3)
  6. Shanu Modi (3)

More People

Years
  1. 2018 (1)
  2. 2013 (1)
  3. 2010 (1)
  4. 2006 (1)
  5. 2005 (1)
Publications
  1. Clinical Breast Cancer (5)

Results (5)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II study of paclitaxel and dasatinib in metastatic breast cancer
    Journal Article

    Morris, P. G.; Rota, S.; Cadoo, K.; Zamora, S.; Patil, S.; D'Andrea, G.; Gilewski, T.; Bromberg, J.; Dang, C.; Dickler, M.; more...
    Clinical Breast Cancer (2018)

    Fulltext@MSK | Save
  • Randomized phase II trial of weekly vs. every 2 weeks vs. every 3 weeks nanoparticle albumin-bound paclitaxel with bevacizumab as first-line chemotherapy for metastatic breast cancer
    Journal Article

    Seidman, A. D.; Conlin, A. K.; Bach, A.; Moynahan, M. E.; Lake, D.; Forero, A.; Wright, G. S.; Hackney, M. H.; Clawson, A.; Norton, L.; more...
    Clinical Breast Cancer (2013)

    Fulltext@MSK | Save
  • Dose dense cyclophosphamide, methotrexate, fluorouracil is feasible at 14-day intervals: a pilot study of every-14-day dosing as adjuvant therapy for breast cancer
    Journal Article

    Drullinsky, P.; Sugarman, S. M.; Fornier, M. N.; D'Andrea, G.; Gilewski, T.; Lake, D.; Traina, T.; Wasserheit-Lieblich, C.; Sklarin, N.; Atieh-Graham, D.; more...
    Clinical Breast Cancer (2010)

    Fulltext@MSK | Save
  • A phase I study of cetuximab in combination with paclitaxel in patients with advanced-stage breast cancer
    Journal Article

    Modi, S.; D'Andrea, G.; Norton, L.; Yao, T. J.; Caravelli, J.; Rosen, P. P.; Hudis, C.; Seidman, A. D.
    Clinical Breast Cancer (2006)

    Fulltext@MSK | Save
  • A phase II trial of gemcitabine in patients with metastatic breast cancer previously treated with an anthracycline and taxane
    Journal Article

    Modi, S.; Currie, V. E.; Seidman, A. D.; Bach, A. M.; Panageas, K. S.; Theodoulou, M.; Moasser, M. M.; D'Andrea, G. M.; Lake, D. E.; Choi, J.; more...
    Clinical Breast Cancer (2005)

    Fulltext@MSK | Save